Approaches pratiques pour des interventions collaboratives
Consolidated Guidelines
Geneva, 2016
The End TB Strategy
Report by the Director-General. 75th World health assembly 25 April 2022
2016 Update
Key population
PQDx 0197-045-00 WHO
PQDx PR
March /2016, version 2.0
PQDx 0181-031-00
WHO PQ Public Report
March/2017, version 3.0
Policy
July 2012
Working Paper No. 3
Accountability for the global health sector strategies, 2016–2021
WHO/CDS/HIV/19.7
The primary role of Benin’s Department of Pharmacy and Medicines (DPMED) is to develop and apply the national pharmaceutical policy. The main objective of this policy is to ensure the availability and accessibility of quality medicines for the population. To fulfill its mandate, DPMED aims to stre...ngthen its regulatory capacity, including the issuance of licenses to pharmaceutical establishments and the registration of pharmaceutical products. Benin’s current registration system shares core concerns that are common to most developing countries, notably the capacity to evaluate and monitor the security, efficacy, and quality of medicines and other health products. It is currently characterized by 1) poor or inadequate traceability of records or regulations (example: a product’s marketing authorization [MA] is often hard to find); 2) lack of evidence used in the regulatory decision-making process (reasons behind special import authorization, i.e., products without valid MAs); 3) inconsistent and unsecured archiving system; 4) limited human resources; and 5) an inefficient information management system
more
· Relevant interventions
· HIV country profiles
· Adolescents country profiles